Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma: A comparison of eight contemporary grading systems

American Journal of Clinical Pathology

Volumn 115, Issue 5, 2001, Pages 709-718

  Leong, A S Y ^a   Sormunen, R T ^a   Vinyuvat, S ^a   Hamdani, R W ^a   Suthipintawong, C ^a  

^a Hunter Area Medical Service   (Australia)

Author keywords

Architecture; c erbB 2; Ductal carcinoma in situ; E cadherin; Estrogen receptor; Grading; Invasive ductal carcinoma; MIB1; Nuclear grade; p27; Progesterone receptor; Vimentin

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P27; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CARCINOMA IN SITU; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; ONCOGENE C ERB; PRIORITY JOURNAL; TUMOR NECROSIS; TUMOR VOLUME; UTERINE CERVIX TUMOR; VAGINA TUMOR; VULVA TUMOR;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL NUCLEUS; DISEASE PROGRESSION; FEMALE; HUMANS; KI-67 ANTIGEN; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; MUSCLE PROTEINS; NECROSIS; NEOPLASM PROTEINS; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0035155505     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/WBU9-22QN-C3NA-2Q12     Document Type: Article

References (51)

1. Epidemiology and natural history of ductal carcinoma in situ
2. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low-grade ductal carcinoma in situ of the breast treated by biopsy
3. The influence of margin width on local control of ductal carcinoma in situ of the breast
4. Prognostic classification of breast ductal carcinoma in situ
5. Noninvasive ductal carcinoma of the breast: Relevance of histologic categorization
6. The classification of ductal carcinoma in situ and its association with biological markers
7. Mammographically-detected ductal carcinoma in situ carcinoma of the breast analyzed with a new classification: A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity
8. Grading of ductal carcinoma in situ
9. Ductal carcinoma in situ of the breast: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein
10. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
11. Ductal carcinoma in situ: A proposal for a new classification
12. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression
13. Metallothionein expression in ductal carcinoma in situ of the breast
14. Comparison of antibodies to estrogen and progesterone receptors and the influence of microwave-antigen retrieval
15. An assessment of the efficacy of the microwave antigen-retrieval procedure on a range of tissue antigens
16. Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: A simplified method with formalin fixation
17. Epitope retrieval with microwaves: A comparison of citrate buffer and EDTA with three commercial retrieval solutions
18. A comparative study of cell proliferation markers in breast carcinomas
19. Pathological prognostic factors in breast cancer, I: The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
20. Duct carcinoma in situ: Pathology and treatment
21. Consensus conference on the classification of ductal carcinoma in situ
22. The measurement of observer agreement for categorical data
23. A critique of contemporary classifications of non-Hodgkin's lymphoma: Which one should we now use?
24. Tumour grade does not change between primary and recurrent mammary carcinoma
25. Immunophenotype of intraductal carcinoma
26. Distribution of estrogen receptor in ductal carcinoma in situ of the breast
27. Intraductal carcinoma associated with invasive carcinoma of the breast: A comparison of the two lesions with implications for intraductal carcinoma classification systems
28. P53 mutations and expression in breast carcinoma in situ
29. A simple index to predict prognosis independent of axillary node information in breast cancer
30. Principles of CDK regulation
31. A cell cycle-regulated inhibitor of cyclin-dependent kinases
32. Vimentin: A new prognostic parameter in breast carcinoma?
33. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors: Prognostic role in breast cancer
34. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction
35. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas
36. Vimentin expression is not associated with poor prognosis in breast cancer
37. Differentiation state and invasiveness of human breast cancer cell lines
38. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells
39. Role of intermediate filaments in migration, invasion and metastasis
40. Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast
41. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive carcinoma
42. Ductal carcinoma in situ of the breast: Reproducibility of histological subtype analysis
43. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up
44. Ductal carcinoma in situ of the breast: The clinical significance of histological classification
45. Consistency achieved by 23 European pathologists in categorising ductal carcinoma in situ of the breast using five classifications
46. Vulvular intraepithelial neoplasia (severe atypia and carcinoma in situ)
47. Comparative genomic hybridization of ductal carcinoma in situ of the breast: Evidence of multiple genetic pathways
48. The clinical behaviour of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ)